Introduction
There are two major (-hexosaminidase isozymes in normal human tissues, hexosaminidase A (af) and hexosaminidases B (33) . Tay-Sachs disease is caused by mutations in the HEXA gene which encodes the a subunit unique to hexosaminidase A. Sandhoff disease results from HEXB gene mutations which affect the common a subunit. Thus, patients with Sandhoff disease have deficiencies of both isoenzymes. The small amount of residual enzyme activity (< 1%) in tissues of these patients is from the labile a homodimer, (3-hexosaminidase S (aa). The stored substrate responsible for the severe neurological disorders characteristic of hexosaminidase A deficiencies is GM2 ganglioside. The a subunit supplies the catalytic site for GM2 hydrolysis (assayable with the artificial substrate 4-methylumbelliferone-(3-N-acetylglucosamine-6-sulfate ) (1 ) , and the (3 subunit confers stability to the active dimer. The (3subunit also contains an active site that is primarily responsible for hydrolyzing neutral substrates; e.g., oligosaccharides (assayable with the artificial substrate 4-methylumbelliferonefl-N-acetylglucosamine ) ( 1 ) which are stored and/ or excreted in elevated amounts only in Sandhoff disease (reviewed in [2, 3] ).
Like other lysosomal storage diseases, Sandhoff disease presents a wide range of clinical phenotypes, from the most severe infantile form (reviewed in [2 ] ) to an adult form in which the primary symptoms are progressive motor neuronopathy (4) ( Table I ). Sandhoff suggests that as little as 10% of the normal level ofhexosaminidase A is compatible with a normal life; i.e., it represents the "critical threshold" of activity necessary to prevent GM2 storage, and that patients with the infantile onset form lack any residual activity towards GM2 ganglioside. Variations within the 1-10% range ofnormal activity may be responsible for the majority of the less severe phenotypes (2, 5, 6).
There have been more than a dozen mutations in the HEXA gene described (reviewed in [3, 7] ). However, only a few HEXB mutations have been characterized. Surprisingly, one of these, a 16-kb deletion of the 5' end, accounted for 27% of the Sandhoff alleles we analyzed (8) . This deletion allele is incapable of transcription due to the absence ofthe 5' promoter region, and in the homozygous form (line GM 294, Table I ) produces a severe infantile phenotype (9) . A patient with the juvenile phenotype (line GM 2094, Table I ) was found to be a genetic compound of the deletion mutation (8) and a G -) A transition in intron 12. The latter creates an alternate splice site and the inframe insertion of eight codons; i.e., 24 nucleotides (10, 11 ) . A third mutation, found in an asymptomatic individual with low enzymatic activity, involves a duplication of a region encompassing the junction of intron 13 and exon 14 . This defect generates an alternate splice site and an inframe insertion of six codons ( 1) . In the juvenile and asymptomatic individuals, a low level of properly spliced (which would produce preprofl-polypeptides with the normal (3-primary structure), produces 3-6% and 9-10% of normal hexosaminidase A activity, respectively ( 11) .
Recently, a novel splicing mutation has been identified in a Japanese patient with juvenile Sandhoff phenotype (Japanese patient, Table I ). The patient, whose parents were first cousins, was shown to be homozygous for a C -) T transition in exon 11 . This mutation, located eight nucleotides downstream from the intron IO/exon 11 junction, impaired mRNA splicing. Two abnormally spliced transcripts were characterized and shown to produce premature stop codons, which are presumably responsible for their instability ( 12) . A small amount of normally spliced mRNA was detected in the patient's cells. Because of the C -T transition, the resulting polypeptide contained an amino acid substitution, Pro417 -> Leu. A second mutation was also found, an A -* G transition in exon 2. This mutation, which results in conversion of Lys121 -Arg, was thought to be a benign polymorphism, for COS cell expression ofa fl-cDNA encoding both the Lys,21 2 Arg and the Pro417 -O Leu substitutions produced levels of intracellular hexosaminidase B activity similar to that of the wild type cDNA. The authors concluded that the splicing mutation (intron IO/exon 11 C --T transition) alone is responsible for the observed clinical phenotype ( 12) .
In this report, we describe a patient with a very mild disease (line 2557, Table I ) whose genotype and low residual enzymatic activity was considered predictive of much more severe juvenile Sandhoff disease. We demonstrate that the patient is a genetic compound ofthe infantile 5' deletion mutation (8) and the juvenile intron IO/exon 11 C -T mutation. The patient's fibroblasts contain < 10% of normal # subunit-mRNA levels and are totally deficient in hexosaminidase B activity; however, they retain 2% of normal hexosaminidase A activity. Despite these data, this individual is 57 years old and has few clinical symptoms. Enzyme analysis ofthe patient's six clinically unaffected siblings indicated that four of them (ages 51-62 yr) are also genetic compounds for the same two Sandhoff alleles. The variable phenotype associated with the intron 10/exon 11 C -* T transition indicates that other unidentified factors determine the pathological outcome of this mutation. We speculate that the severity of the effect of the mutation on the levels of properly spliced f subunit-mRNA may be determined by individual variations in the RNA splicing machinery.
Methods
Case report. The subject was a 57-yr-old non-Jewish French-Canadian who presented in 1986 with a 9-yr history of severe watery diarrhea, intermittent moderate and diffuse abdominal pain, 17- Sainte-Justine, Universite de Montr6al, for further study.
The patient (II-7, Fig. 1 ) is one of seven siblings. One of his sisters, age 58 (11-3, Fig. 1 ), has also complained of diarrhea for the last 10 yr and of postural dizziness for 5 yr. Clinical investigations similar to those described above were carried out with normal results. There has been no reported change in the state ofour patient or any ofhis siblings during the past 5 yr.
Measurements of residual hexosaminidase isozymes and urinary oligosaccharides. Fibroblasts (three T-75 flasks) derived from normal individuals and patients with Sandhoff disease were harvested and lysed in buffer that contained 50 mM Tris-HCl pH 7.5, 10 4M DTT, 10-3M EDTA, and 5% glycerol within 3 wks of reaching confluence. Protein was determined by the method of Lowry. Separation of the fl-hexosaminidase isozymes (Hex B, Hex A, and Hex S) was accomplished by chromatofocusing and the hexosaminidase activity in each fraction determined by assay with 4-MUG as previously reported (4, 9) . Alternatively, hexosaminidase A (aB) and B ((3j3) were separated from hexosaminidase S (aa) by immunoprecipitation with sheep anti-# antiserum coupled to Protein G Sepharose (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, NJ) as previously described ( 13 ) . The hexosaminidase A bound to the beads was assayed directly using the a-specific substrate 4-MUGS ( 14) . The total precipitated hexosaminidase activity (A and B) was assayed with the common 4-MUG substrate. The hexosaminidase isozymes in plasma and leucocytes were assayed with 4-MUG by the thermodenaturation assay method ( 15) . Oligosaccharides in a 24-h urine collection were determined by thin-layer chromatography ( 16) .
Western blot analysis. Samples ofcell lysates (Table I) were individually mixed with sample buffer containing 3% SDS and 25 mM DTT, and incubated at 60'C for 15 min. The proteins in each sample were separated by SDS-PAGE using the Laemmli gel system ( 10% gel) ( 17) . The proteins were transferred to nitrocellulose overnight ( 13 ) . Nitrocellulose was blocked by exposure to 5% skim milk in Blotto (10 mM Tris base, 150 mM NaCI, 0.05% Tween 20, pH 7.5) for 4 h with gentle shaking, then incubated with a 1:800 dilution ( 1% skim milk in Blotto) of rabbit anti-# IgG, overnight. Nitrocellulose was washed 4x with 1% skim milk in Blotto and incubated with a 1:10,000 dilution ( 1% skim milk in Blotto) ofgoat anti-rabbit IgG/horse radish peroxidase conjugated (Sigma Chemical Co., St. Louis, MO) for 1 h. The nitrocellulose was then washed 4X 15 min with 1% skim milk in Blotto, quickly rinsed with Blotto (no skim milk), and dried between filter papers. It was then incubated in equal volumes ofDetection reagent 1 and Detection reagent 2 (ECL system; Amersham Corp., Arlington Heights, IL) for precisely 1 min, dried briefly on filter papers, covered with Saran wrap, and exposed to Hyperfilm-ECL (Amersham) for 1 min.
Cell culture. Fibroblast cells were cultured in a-minimal essential medium (MEM; Flow Laboratories) supplemented with streptomycin, penicillin (100 mg/I each), and 10% fetal calf serum at 370C under 5% CO2.
Preparation ofgenomic DNA. Cultured fibroblast cells, grown to confluency in 6 X 150 cm2 culture dishes, were harvested in PBS by scraping with a rubber policeman. The cells were centrifuged at 2,000 rpm for 10 min and the pellet resuspended in 2 ml TE buffer (10 mM Tris-HCI, pH 8/1 mM EDTA). An equal volume of TE/0.2% SDS was added and the tube inverted gently to lyse the cells. The DNA was extracted with phenol, precipitated with ethanol, and resuspended in distilled H20 to 0.5% ughld for amplification by polymerase chain reaction (PCR).
Preparation of whole cell RNA. Total cellular RNA was prepared from cultured fibroblast cells by the guanidinium isothiocyanate method ( 18) followed by CsCl ultracentrifugation. Northern blot analysis was carried out as previously reported (4, 9) .
Reverse transcription ofRNA. PCR. Amplification of exonic and intron/exon junctions from genomic DNA, and cDNA segments was performed by the PCR procedure, using the oligonucleotide primers as described previously (12) . The reactions were performed in 100 Ml vol containing 0.1-0.5,Mg genomic DNA or 2 Ml cDNA, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, 200,uM each offour dNTP's, 0.5 Mg ofeach primer and 2.5 U AmpliTaq. Taq polymerase. Amplification was achieved by incubation in a DNA Thermal Cycler" (Perkin Elmer Cetus Instrs., Norwalk, CT) for 30 cycles, each consisting of a denaturation step at 94°C for 30 s, an annealing step at 55°C-65°C (usually at 5°C below the melting temperature (Tm) of the primers) for 30 s and an extension step at 72°C for 1.5-3 min (depending on the length of DNA to be amplified). 1/ 10th ofthe amplified products were analyzed by agarose gel electrophoresis. All splice junctions and exonic sequences of the HEXB gene from cultured fibroblasts of patient 2557 were amplified and sequenced.
The region around exon 11, found to be heterozygous for the Pro417 -* Leu mutation in genomic DNA was amplified by PCR using oligonucleotides "528" (3' intron 9, sense; 5'-CACCTCTCAAAA-TGCAAGAA-3') and "529" (5', intron 11, antisense; 5'-AAT-GGTTGCTTCACTTACCA-3'). Oligonucleotide "52" (5'-CTC-CAATCTTGTCCATAGCT-3') was used as a primer for direct sequencing. A fragment ofcDNA containing this region ofexon 11 was amplified by PCR using primers " 18" (sense; 5 '-TGTTGGG-AATCAAATCCAAAA-3') and "13" (antisense; 5'-CAGTCTGT-CATAGGCGTCAT-3'). Genomic DNA from fibroblasts ofa normal control and the subject was amplified by PCR using oligonucleotides "2-1 " (3' intron 1, sense; 5'-GAGTTAACTACAATGTTACTAG-3') and "2-2" (5', intron 2, antisense; 5'-GGAAGCTTAATAGGAATCATAAACTC-3'; a Hind III site in the primer is underlined) in the region of exon 2 where the Japanese patient was previously reported to have a second Lys121 -0 Arg substitution, as well as the same Pro417 --Leu mutation (12) we now report in our patient, 2557 (see Results). The product was sequenced directly using oligonucleotide 2-1 as primer. An area in exon 6 of genomic DNA from our patient, line 2557, was amplified and directly sequenced with primers "891" (3', intron 5, sense; 5'-AGACA-TATGGAAGGAATTCCAA-3'; an EcoRI site in the primer is underlined) and "892" (5', intron 6, antisense; 5'-AACTTGTAATGAAAC-TATACCCA-3'). cDNA was amplified in this region by PCR with primers "15" (sense; 5'-GGTTTCTACAAGTGGCATCA-3') and "10" (antisense; 5'-ATGTTGTATTCAGAGTAGGG-3').
Direct sequencing. In preparation for sequencing, DNA amplified by PCR was purified from unincorporated primers and extraneous bands by electrophoresis in an 8% polyacrylamide gel. The DNA was excised and eluted overnight with shaking incubation at room temperature in distilled H20. DNA was freed oftraces ofacrylamide by passage through siliconized glass wool and precipitated twice by addition of 1/ 10 vol sodium acetate (pH 4.8) and 2 vol absolute ethanol.
DNA was resuspended in 10 Ml distilled H20. Direct sequencing was performed on 2-5 M1 samples with [ a 35SIdATP using a modification of the Sequenase" protocol (United States Biochemical Corp.
Cleveland, OH), by supplementing all buffers with 10% DMSO and 50 MM NaCl, as described by Winship (19) . Samples were electrophoresed in 6% polyacrylamide/ urea gels.
Results
The identification of MCBs in the patient's intestinal neurons led to the investigation of residual hexosaminidase levels (by the standard thermodenaturation assays [ 15 ] ) in plasma (Fig.  1) . The shown some symptoms similar to those of our patient (see case report); the others were asymptomatic. The above activity data led to a more quantitative evaluation of the hexosaminidase isozymes in fibroblasts (line 2557) from our patient, as well as an estimation of the relative steady state level of mature (i.e., lysosomal, fi subunit protein [Western blot]). These data were compared to those obtained from the fibroblasts ofother patients with known genotypes and phenotypes (GM 2094, juvenile; 2400, adult; 2399, adult; and GM 294 infantile; Table I ). The chromatofocusing separation of the hexosaminidase isozymes from four of these cell lines (2557, GM 294, GM 2094, and 2400) is shown in Fig. 2 . The isozyme pattern from our patient's cell lysate was virtually identical to that of cell line GM 2094 from the juvenile Sandhoffpatient. Both of these lines clearly produced more residual hexosaminidase A than did the infantile/deletion line, GM 294, and less than the cell line from the adult Sandhoffpatient, 2400. The quantitation of the enzymatic activity levels is presented in Table II (Chromatofocusing). These results were corroborated by a solid state assay that selectively immunoprecipitates hexosaminidase A and B, but not hexosaminidase S (aa), with an anti-,B antiserum (20), and then quantitates both isozymes using the common 4-MUG substrate, or quantitates hexosaminidase A alone using the a-specific 4-MUGS as a substrate (Table II, Immunoprecipitation) . Mature fl subunits contained in lysates from all four patients' fibroblasts were undetectable when compared with similar amounts of total protein from a normal cell lysate (data not shown). However, when the amount of lysate protein loaded from the patients' cells was increased 20-100-fold over that loaded from the normal cell lysate, mature f, protein in the 28-kD range (13) was detectable (Fig. 3) . As was the case with the enzymatic activity, when the variation in total protein load was taken into account similar amounts of f protein were present in lysates from our patient's cells and those from line GM 2094, larger amounts (12) . 1 Indicate the highly probable, but experimentally unproven presence of the mutation. Demonstrated by Wakamatsu et al. not to affect the function ofthe a-protein (12) . ' Translated from a small amount of properly spliced ,B subunit mRNA. ** Demonstrated in this report and by Wakamatsu et al. to be a normal polymorphism (12) .
were found in line 2400, and no , protein was detected in the deletion line GM 294.
The enzymatic and Western blotting data indicated the presence of mutation(s) in the patient's HEXB gene. In order to predict the type of mutation(s) that could be present we determined the levels of a and is subunit-mRNA in the patient's fibroblasts by Northern blotting. Fig. 4 (panels " (3- Hexosaminidase, a-chain" and "fl-Glucuronidase") demonstrates that levels of a-mRNA transcribed by the HEXA gene and the control mRNA (encoding fl-glucuronidase (21) were similar in the patient's cell line (lane 4), those of the normal control (lane 1), and those from two sisters with adult onset Sandhoff disease (lines 2399 and 2400; lanes 2 and 3) (4).
However, the level of ft subunit-mRNA in our patient's cells was decreased to less than 10% of normal levels (Fig. 4 , fl-Hexosaminidase, ,8-chain, lane 4). We initially determined that our patient (line 2557) and the adult Sandhoff patients are heterozygous for the common partial 5' end deletion mutation (8 Fig. 4 cannot detect differences in levels . 50% of normal mRNA; i.e., the adult-onset patients appear to have normal levels of (3 subunit-mRNA. However, the severely reduced level of ( subunit-mRNA in our patient's cells, which is similar to the levels of residual enzymatic activity and fl-crossreactive material (CRM), suggest that his second allelic mutation primarily exerts its detrimental effect by lowering the level of ( subunit-mRNA.
In order to identify the patient's second HEXB gene mutation, all exons and intron/exon junctions from his genomic DNA were amplified by PCR and the resultant DNA sequenced directly. Only two changes from the normal sequence were found, both in a heterozygous form. The first was a C -G transition in the codon for Ser243 in exon 6, which would result in its substitution by Cys (data not shown). The second was a C -. T transition in the codon for Pro417 in exon 11 (Fig. 5) . This transition was the same mutation found in a homozygous form in cells from the Japanese juvenile Sandhoff patient with reduced (3 subunit mRNA levels (Table I) . We suspected the intron 10/exon 11 C --T transition to be directly responsible for the lower (3 subunit mRNA levels in our patient. The C --G transition in exon 6 could result in a silent polymorphism or be present on the exon 1-5-deleted allele. :.:.,.F igure 2. Chromatofocusing elution profiles of the hexosaminidase isozymes; activities were obtained from total fibroblast extracts. The nmol of 4-MUG hydrolysed per h in each fraction were normalized as described in (9), by dividing each value by the total number of units of f3-galactosidase activity contained in the cell extract applied to the column (X 100) (9) . These values were plotted versus the fraction number. Small open circles represent the separation of isozyme from one oftwo previously described adult onset Sandhoff patients, cell line 2400 (4), open squares represent the infantile deletion line GM 294, juvenile onset line GM 2094 is represented by open diamonds, and closed circles represent the subject of this report (to compare these patterns with those obtained for fibroblasts derived from normal and carrier individuals see reference [9] ).
To determine if the C -> G transversion in exon 6 and/or the C -. T transition in exon 11 were transcribed, we analyzed the nucleotide sequences of our patient's cDNA in the regions of the two substitutions. Amplification of the region encompassing the exon 6 transition produced a single fragment ofthe expected length (data not shown). Direct sequencing of this fragment showed that it contained only the nucleotide needed to code for the wild type Ser residue (data not shown). Thus, the C -* G transition is not transcribed and must reside in exon 6 of the partially deleted allele. On the other hand, amplifica- ( 11) .
tion of the region containing the C -* T transition at the codon for Pro417 produced three major fragments (Fig. 6) . One, at 425 bp (P1) was the expected size for properly spliced ,B subunitmRNA. The other two, 313 bp (P2) and 255 bp (P3), were similar in size to the two abnormally spliced ,B subunit-mRNA species described in fibroblasts from the Japanese patient ( 12) . P1 was confirmed to be normally spliced subunit-mRNA by direct sequencing. Its sequence contained only the mutant "T" nucleotide at the codon for Pro417 (Fig. 7 A) . As was the case with the Japanese juvenile Sandhoffpatient ( 12 ) , P2 displayed a sequence corresponding to exon 10 spliced to a cryptic site mid-way in exon 11 (a TGA premature stop codon is generated six nucleotides after the junction (Fig. 7 B) and P3 displayed the sequence ofexon 10 spliced directly to exon 12 ( Fig. 7 B) (a premature stop codon would be generated 171 nucleotides after the junction). The cloned genomic DNA from the Japanese juvenile Sandhoffpatient was also reported to contain a point mutation that would result in a Lys121 -* Arg substitution (Table I) mal polymorphism ( 12) . To determine if our patient also harbored this mutation, we amplified genomic DNA from line 2557 and from normal control leukocytes in the affected region of exon 2. As shown by the sequence analysis in Fig. 8 , DNA from our patient contains only the normal Lys codon 121 (Fig.  8, Patient) . Surprisingly, one of the HEXB alleles from a normal control was found to contain the Arg codon substituted at position 121 (Fig. 8, Normal) . Fresh serum and leukocytes were isolated from the blood of the control individual (R.T.), and they both were tested for total hexosaminidase activity and percentage of hexosaminidase B (of the total) by the thermodenaturation assay (22, 23) . The results from both sources of enzyme were in the normal range (Table III) . These data confirm that the Lys121 -> Arg substitution is a normal polymorphism. Furthermore, they suggest that the intron 10/exon 11 C --T transition mutation in our patient's and the Japanese patient's HEXB genes have arisen independently.
Discussion
Determination of our patient's genotype revealed that he is a compound heterozygote for two mutant HEXB alleles. One of these we previously reported to be the common Sandhoff 5' deletion allele which is not transcribed (8) . Direct sequencing of PCR fragments from genomic DNA and cDNA revealed that the mutation in our patient's second HEXB allele is a C -> T transition 8 nucleotides downstream from the intron 10/ exon 11 junction (Fig. 5 ). This mutation in the homozygous form was shown to impair ,3 subunit-mRNA splicing in a Japa- correlated with the residual 8% activity level found in the Japanese patient's fibroblasts ( 12) . However, amplification of this region of our patient's cDNA produced three fragments ( directly. The largest cDNA from patient 2557 displays a C -* T transition at the codon for Pro4,7 in exon 11 (indicated by * as a G -A transition in the antisense sequence). This results in the substitution ofa codon for Leu. In this product, exon 10 is correctly spliced to exon 11 (A). The two smaller products display anomalous splicing. 2557 middle shows exon 10 spliced to a cryptic site midway in exon 11 (at Asp452), resulting in a frame-shift with a stop codon. 2557 smallest shows exon 10 spliced to exon 12, to the exclusion of exon 1 1. This also results in a frame-shift, which introduces a stop codon 171 bases downstream (A).
mRNA (Fig. 7) . The two smaller misspliced mRNA species result in premature stop codons that are presumably responsible for their low steady state levels (24) (25) (26) . The new splice sites identified in Fig. 6 were identical to those identified from cDNA of the Japanese juvenile Sandhoff patient ( 12) . The genomic DNA from the Japanese patient also encoded a Lys121 --Arg substitution. COS cell expression studies sug- (27) , amino terminus Thr,22 (28) , and a Lys -Arg substitution should not affect proteolytic processing. It should also be noted that the pro-hexosaminidase A is fully active (29) , thus GM2 ganglioside hydrolysis can occur with or without the presence of Lys121 in the 13 subunit. Genomic DNA from our patient did not contain the above Lys12, --Arg substitution. This demonstrates that the intron 1O/exon 11 C -T mutation is present in two different genetic backgrounds and, therefore, probably arose independently in the Japanese and Caucasian populations. The observation that this C --T transition affects splicing in exactly the same novel were noted in the Japanese juvenile ( 12) and the French-Canadian adult onset patients; e.g., cell line 2400 (4) . However, the Japanese patient and the adult onset patients had additional clinical symptoms indicating neurological and/or motor neuron involvement (Table I) . Furthermore, our patient was not found to excrete detectable amounts of neutral oligosaccharides (data not shown). Both the Japanese patient and the adult Sandhoffpatients were shown to excrete large amounts of these compounds (4, 12) (Table I) . As with 4-MUG hydrolysis, oligosaccharide hydrolysis is primarily accomplished by the active site of the /3 subunit in hexosaminidase A and B ( 1) . Thus, it is even more surprising that our patient does not excrete oligosaccharides given the substantially lower residual hexosaminidase activity and fl-CRM levels found in his fibroblasts, as compared to fibroblasts from the adult onset Sandhoffpatient (Table II) . These data suggest that our patient may express variable levels of residual activity in different tissues; i.e., above the critical threshold in most tissues including the brain, kidney, and liver, but below the threshold in others, such as intestinal and other autonomic neurons, and fibroblasts.
The reason for the above variations in phenotypic expression is unclear. One possibility is that tissue-specific differences in our patient, and the overall clinical differences between him and the Japanese patient, could result from small variations in the level of properly spliced /3 subunit-mRNA. The splicing of mRNA involves a large number of gene products (reviewed in [30] ) and this mutation is at a site not previously thought to be part of the consensus sequence for splice junctions. It has also been documented that the normal nucleotide sequence at the intron 10/exon 11 junction in the HEXB gene does not fully conform to the consensus sequence for a splice junction ( 31 ). This is consistent with the observation of some (0.6%) abnormally spliced A subunit mRNA; i.e., P2, in amplified cDNA from normal fibroblasts (12 
